PHARMACEUTICAL TECHNOLOGY — Heparin Importer Profile
Pharmaceutical Importer · #18 buyer for Heparin · $2.1M import value · 64 shipments · DOMINICAN REPULIC · DGFT Verified
PHARMACEUTICAL TECHNOLOGY is the #18 importer of Heparin from India with $2.1M in import value and 64 verified shipments. PHARMACEUTICAL TECHNOLOGY holds a 0.8% market share in Heparin imports based in DOMINICAN REPULIC. The company sources from 1 verified supplier across 41 formulations shipped to 2 countries. Overall, PHARMACEUTICAL TECHNOLOGY imports 7 pharmaceutical products worth $9.8M across 4 therapeutic categories.
PHARMACEUTICAL TECHNOLOGY — Heparin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Heparin to PHARMACEUTICAL TECHNOLOGY?
Verified from 64 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $2.1M | 64 | 100.0% |
PHARMACEUTICAL TECHNOLOGY sources Heparin from 1 verified Indian supplier based on 64 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does PHARMACEUTICAL TECHNOLOGY Compare to Nearest Heparin Importers?
Buyers ranked immediately above and below #18 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | BOSTON ONCOLOGY ARABIA | SAUDI ARABIA | $11.2M | 223 | $50.0K |
| 6 | FRESENIUS KABI USA LLC | UNITED STATES | $3.5M | 69 | $50.0K |
| 18 | PHARMACEUTICAL TECHNOLOGY ★ | DOMINICAN REPUBLIC | $3.0M | 64 | $46.4K |
| 7 | MYLAN INSTITUTIONAL INC 2898 | UNITED STATES | $2.9M | 57 | $50.0K |
| 12 | NORDIC PHARMACEUTICAL COMPANY SAC | PERU | $2.7M | 54 | $50.0K |
PHARMACEUTICAL TECHNOLOGY ranks #18 among 854 Heparin importers from India. Average shipment value of $46.4K compared to the market average of $80.1K. The closest competitors by value are BOSTON ONCOLOGY ARABIA and FRESENIUS KABI USA LLC.
Where Does PHARMACEUTICAL TECHNOLOGY Import Heparin To?
Destination countries from 64 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| DOMINICAN REPULIC | $1.2M | 36 | 60.6% |
| DOMINICAN REPUBLIC | $812.2K | 28 | 39.4% |
PHARMACEUTICAL TECHNOLOGY imports Heparin to 2 countries. The primary destination is DOMINICAN REPULIC receiving 60.6% of shipments worth $1.2M.
What Heparin Formulations Does PHARMACEUTICAL TECHNOLOGY Import?
| Formulation | Value | Shipments |
|---|---|---|
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN | $349.7K | 8 |
| HEPARIN SODIUM INJECTION 25000 IU/5ML(5000 IU/ML) | $164.8K | 4 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,40MG IN 0.4ML PRE-FILLED SYRINGE (MEXAPARIN 40MG/0.4ML) | $141.3K | 3 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 40MG IN 0 4ML PRE FILLED SYRINGE MEXAPARIN 40MG 0 4ML | $113.6K | 3 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP 20MG PRE FILLED SYRINGES | $100.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP, 40MG IN 0.4ML PRE-FILLED SYRINGE (MEXAPARIN 40MG/0.4ML) | $100.0K | 2 |
| LOW MOLECULAR WEIGHT HEPARIN ENOXAPARINSODIUM INJECTION USP,60MG IN 0.6ML PRE-FILLED SYRINGE (MEXAPARIN 60MG/0.6ML) | $81.7K | 3 |
| HEPARIN SODIUM INJECTION 25000 IU/5ML (5 | $76.1K | 2 |
| HEPARIN SODIUM INJECTION 25000 IU/5ML(5000 IU/ML)NOS | $65.6K | 3 |
| HEPARIN INJECTION 25000IU/5ML VIAL (HEPA | $50.0K | 1 |
PHARMACEUTICAL TECHNOLOGY imports 41 distinct Heparin formulations from India. The top formulation is LOW MOLECULAR WEIGHT HEPARIN ENOXAPARIN with 8 shipments worth $349.7K.
Who Are the Top Buyers of Heparin from India and How Much Does PHARMACEUTICAL TECHNOLOGY Import?
India exported $68.4M worth of Heparin through 4,586 shipments from 391 suppliers to 137 countries, serving 854 buyers globally. PHARMACEUTICAL TECHNOLOGY imports $2.1M of this total, accounting for 0.8% of India's Heparin exports with 64 shipments from DOMINICAN REPULIC. This is verified from 64 customs shipment records covering 41 distinct formulations.
What Is the Average Order Value for PHARMACEUTICAL TECHNOLOGY's Heparin Imports?
PHARMACEUTICAL TECHNOLOGY's average Heparin order value is $32.2K per consignment, based on 64 shipments totaling $2.1M. PHARMACEUTICAL TECHNOLOGY is based in DOMINICAN REPULIC and ranks #18 among all Heparin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Heparin to PHARMACEUTICAL TECHNOLOGY?
PHARMACEUTICAL TECHNOLOGY sources Heparin from 1 verified Indian supplier: GLAND PHARMA LIMITED ($2.1M, 100.0%). This is based on 64 customs records.
How Does PHARMACEUTICAL TECHNOLOGY Compare to Other Heparin Importers?
PHARMACEUTICAL TECHNOLOGY ranks #18 among 854 Heparin importers from India with a 0.8% market share. The top 3 importers are FRESENIUS KABI USA, LLC ($19.4M), EVERSANA ($13.4M), BOSTON ONCOLOGY ARABIA ($11.2M). PHARMACEUTICAL TECHNOLOGY processed 64 shipments from DOMINICAN REPULIC.
What Other Cardiovascular Products Does PHARMACEUTICAL TECHNOLOGY Import?
PHARMACEUTICAL TECHNOLOGY also imports these cardiovascular products. Each links to the detailed product page.
About PHARMACEUTICAL TECHNOLOGY
PHARMACEUTICAL TECHNOLOGY imports 7 products worth $9.8M. Beyond Heparin, top products include Enoxaparin, Syringe, Nifedipine, Irbesartan, Miconazole. View the complete PHARMACEUTICAL TECHNOLOGY profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Heparin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Heparin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: PHARMACEUTICAL TECHNOLOGY matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as PHARMACEUTICAL TECHNOLOGY's capped import value divided by total capped export value for Heparin across all Indian exporters.
- 5.Verified Records: This page is backed by 64 individual customs records matching PHARMACEUTICAL TECHNOLOGY importing Heparin, covering 41 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 137+ countries, 854+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Heparin Import Data for PHARMACEUTICAL TECHNOLOGY
Access order-level details, pricing data, supplier connections, and competitive analysis for PHARMACEUTICAL TECHNOLOGY's Heparin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
PHARMACEUTICAL TECHNOLOGY
Full Company Profile →
7 products · $9.8M total trade · 4 categories
PHARMACEUTICAL TECHNOLOGY × Heparin
Verified from customs records
Company Overview
Top Products by PHARMACEUTICAL TECHNOLOGY
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for PHARMACEUTICAL TECHNOLOGY.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Heparin. For current order-level data, contact TransData Nexus.